No matter how challenging, disruptive innovation needs capital to succeed. BioVale can help academics, start-ups, small or medium-sized businesses (SMEs) and industry build consortia and access funding for bio-based innovation along the value-chain.
Grant funding for:
Industry-academia knowledge exchange
The transfer of knowledge between organisations is key to innovation. Funding possibilities include CASE studentships which fund PhD students to work on projects co-defined and co-supervised by an industry partner. Knowledge Transfer Partnerships (KTPs) enable academic institutions to employ recently qualified graduates to work at the partner company for between six months and three years. The Networks in Industrial Biotechnology and Bioenergy provide business interaction vouchers and funding for Proof of Concept projects.
Feasibility studies and collaborative R&D
Research, demonstration and flagship projects
The Bio-based Industries Joint Undertaking (BBI JU) invests more than €200m per annum as part of the EU’s Horizon 2020 funding programme. BBI JU is Europe’s bioeconomy partnership between the public EU and private industry consortium BIC. Find out more.
Large-scale capital expenditure funds
The EU Innovation Fund distributes the funds generated by the EU’s carbon pricing system to support the building of low carbon technologies at scale. UK businesses can participate as consortium partners though the project site itself should be in an EU member state.
Public private partnership investment funds:
Europe’s Circular Bioeconomy Fund
The UK’s Clean Growth Fund
The £20 million Clean Growth Fund for UK-based start-ups was set up in May 2020 to drive green technology in the power, transport, waste and building energy efficiency sectors.
BioVale has contacts with a range of investors active in the bioeconomy, including VC, private equity, angel and high net worth individuals. All are keen to scout out the next commerciable bio-based product, process or technology.
There are also fully-funded regional support opportunities accessible to bio-based businesses.